• By clicking "OK" or continuing to use this site, you agree that we may collect and use your personal data and set cookies to improve your experience and customise advertising. To see how, and to learn how to control cookies, please read our Privacy Policy and Cookie Policy.
OK
Advertisement
In the last 7 days
In the last month
Moderna (MRNA) Stock Jumps 7.5% in One Day FinanceFeeds12:06 25-Nov-24
Rio Tinto, housebuilders, Moderna: What brokers said today Proactive Investors (UK)16:23 19-Nov-24
StockWatch: Vaccine, ETF Shares Drop as Trump Chooses RFK Jr. for HHS Genetic Engineering and Biotechnology News21:28 16-Nov-24
Shares in vaccine makers decline following Kennedy appointment Proactive Investors (Australia)03:57 15-Nov-24
Stock Watch: Q3, Bonfire Of The Vaccine Manufacturers Scrip Pharma Intelligence13:29 13-Nov-24
Morrison government’s $2 billion vaccine deal blasted The Sydney Morning Herald18:01 12-Nov-24
Moderna’s mRESVIA vaccine gains Health Canada approval Pharmaceutical Technology11:46 11-Nov-24
view more headlines
5 Dec 16:33

About our Moderna news

Latest news on Moderna, a pharmaceutical and biotechnology company based in Cambridge, Massachusetts, that focuses on RNA therapeutics, primarily mRNA vaccines.


Publication filters

Headline Density

Sorry, no headlines or news topics were found. Please try different keywords.